Seeking Alpha

Nestle (NSRGF.PK) agrees to buy Prometheus Laboratories, a maker of treatments for cancer and...

Nestle (NSRGF.PK) agrees to buy Prometheus Laboratories, a maker of treatments for cancer and gastrointestinal illnesses. Financial terms weren't disclosed, but Nestle may have paid 500M-1B Swiss francs ($567M-$1.1B) for the San Diego firm.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio:

|